항-NMDA-수용체 뇌염으로 진단된 긴장증 사례
A Case of Catatonia Later Diagnosed with NMDA Receptor Encephalitis
0
조회
0
다운로드
1
인용
0
참고문헌
초록
We report a case of a young female patient with catatonic features who later turned out to be suffering from an anti-NMDA (N-methyl- D-aspartate)-receptor-antibody encephalitis. A previously healthy 21-year-old woman was admitted to psychiatric inpatient care presenting with acute psychotic behavior with catatonic features. Laboratory tests of serum and CSF (Cerebrospinal fluid), EEG (Electroencephalogram), brain MRI (Magnetic Resonance Imaging) were unremarkable except vague slow wave on EEG. However, subtle cognitive impairment at the bedside examination suggested further imaging studies to rule out possible organic etiology like autoimmune encephalitis. Brain PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) suggested probable inflammation in the brain. In case of autoimmune encephalitis, given the severity of symptoms and worsening course, steroid pulse therapy was initiated promptly even though the diagnosis was not confirmed but presumed at that time. She recovered completely with steroid therapy. Later her disease turned out to be anti-NMDA-receptor-antibody encephalitis by the antibody test which was not available at the time of admission. Psychiatrists need to be aware of autoimmune encephalitis like anti-NMDA-receptor-antibody encephalitis in the differential diagnosis of acute psychosis with catatonic features. Subtle cognitive impairment which tends to be overlooked due to catatonic features might be a clue to suspect the organic etiology.
Abstract
We report a case of a young female patient with catatonic features who later turned out to be suffering from an anti-NMDA (N-methyl- D-aspartate)-receptor-antibody encephalitis. A previously healthy 21-year-old woman was admitted to psychiatric inpatient care presenting with acute psychotic behavior with catatonic features. Laboratory tests of serum and CSF (Cerebrospinal fluid), EEG (Electroencephalogram), brain MRI (Magnetic Resonance Imaging) were unremarkable except vague slow wave on EEG. However, subtle cognitive impairment at the bedside examination suggested further imaging studies to rule out possible organic etiology like autoimmune encephalitis. Brain PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) suggested probable inflammation in the brain. In case of autoimmune encephalitis, given the severity of symptoms and worsening course, steroid pulse therapy was initiated promptly even though the diagnosis was not confirmed but presumed at that time. She recovered completely with steroid therapy. Later her disease turned out to be anti-NMDA-receptor-antibody encephalitis by the antibody test which was not available at the time of admission. Psychiatrists need to be aware of autoimmune encephalitis like anti-NMDA-receptor-antibody encephalitis in the differential diagnosis of acute psychosis with catatonic features. Subtle cognitive impairment which tends to be overlooked due to catatonic features might be a clue to suspect the organic etiology.
참고문헌 (35)
- Kahlbaum K, "Catatonia" (1973), Johns Hopkins University Press
- Kraepelin E, "Dementia praecox and paraphrenia" (1971), Krieger Publishing Company
- Blueler E., "Dementia Praecox or The Group of Schizophrenias" (1911), International Universities Press
- American Psychiatric Association, "Association AP. Diagnostic and statistical manual of mental disorders", ~ (1980)
- Morrison JR, "Catatonia: retarded and excited types", Archives of General Psychiatry, 28, pp.39~41 (1973)
- Morrison JR, "Karl Kahlbaum and catatonia", Comprehensive Psychiatry, 15, pp.315~316 (1974)
- Taylor MA, "Catatonia: prevalence and importance in the manic phase of manic-depressive illness", Archives of General Psychiatry, 34, pp.1223~1225 (1977)
- Abrams R, "Catatonia and mania: patterns of cerebral dysfunction" (1979), Biological Psychiatry
- Abrams R, "Catatonia: a prospective clinical study", Archives of General Psychiatry, 33, pp.579~581 (1976)
- Gelenberg A, "The catatonic syndrome", The Lancet, 307, pp.1339~1341 (1976)
- Fink M, "Catatonia: a separate category in DSM-IV?", ~ (1991)
- Association AP, "Diagnostic and statistical manual of mental disorders (DSM)", pp.143~147 (1994), American Psychiatric Association
- Tandon AP, "Catatonia in DSM-5", Schizophrenia Research, 150, pp.26~30 (2013)
- Association AP, "Diagnostic and Statistical Manual of Mental Disorders (DSM-5®)" (2013), American Psychiatric Pub
- Fink M, "Catatonia: A Clinician’s Guide to Diagnosis and Treatment" (2003), Cambridge University Press
- Rao NP, "Has Kahlbaum syndrome disappeared or is it underdiagnosed? Reexamining the nosology of catatonia", J ECT, 28, pp.62~63 (2012)
- Daniels J, "Catatonia: clinical aspects and neurobiological correlates", J Neuropsychiatry Clin Neurosci, 21, pp.371~380 (2009)
- Kroll KE, "Catatonia in the Emergency Department", J Emerg Med (2012)
- Ungvari GS, "The pharmacological treatment of catatonia: an overview", Eur Arch Psychiatry Clin Neurosci, 251, pp.31~34 (2001)
- Rohland BM, "ECT in the treatment of the catatonic syndrome", J Affect Disord, 29, pp.255~261 (1993)
- Rosebush PI, "Current Clinical Neurology: Psychiatry for Neurologists", pp.81~92 (2006), Humana Press Inc.
- Fawcett RG, "Acute psychosis associated with anti-NMDA-receptor antibodies and bilateral ovarian teratomas: a case report", J Clin Psychiatry, 71, pp.504~ (2010)
- Consoli A, "Malignant catatonia due to anti-NMDAreceptor encephalitis in a 17-year-old girl: case report", Child Adolesc Psychiatry Ment Health, 5, pp.15~ (2011)
- Waxman EA, "N-methyl-D-aspartate receptor subtypes:multiple roles in excitotoxicity and neurological disease", Neuroscientist, 11, pp.37~49 (2005)
- Coyle JT, "Glutamate and schizophrenia: beyond the dopamine hypothesis", Cell Mol Neurobiol, 26, pp.365~384 (2006)
- Vincent A, "Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults", Lancet Neurol, 7, pp.1074~1075 (2008)
- Wandinger KP, "Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis", J Neuroimmunol, 231, pp.86~91 (2011)
- Manahan-Vaughan D, "A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats", Hippocampus, 18, pp.125~134 (2008)
- Dalmau J, "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies", Lancet Neurol, 7, pp.1091~1098 (2008)
- Dalmau J, "Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis", Lancet Neurol, 10, pp.63~74 (2011)
- Titulaer MJ, "Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study", The Lancet Neurology, 12, pp.157~165 (2013)
- Padma S, "PET", CT in the evaluation of anti-NMDA-receptor encephalitis: What we need to know as a NM physician, 2011, pp.26, 99~101
- Frechette ES, "Prolonged follow-up and CSF antibody titers in a patient with anti-NMDA receptor encephalitis", Neurology, 76, pp.S64~S66 (2011)
- 신규식, "조현병의 증상으로 발현한 신생물딸림변연뇌염 1예", 신경정신의학, 54(4), pp.596~599 (2015), 대한신경정신의학회[DOI]
- 이형석, "정신분열병의 임상증세를 보였던 항NMDA수용체뇌염", 대한신경과학회지, 31(2), pp.115~117 (2013), 대한신경과학회